Multiple myeloma – March 2021 Multiple myeloma – March 2021 Pivotal study results of Idecabtagene Vicleucel in relapsed and refractory multiple myeloma published in New England Journal of Medicine 24 Feb 2021 Idecabtagene Vicleucel (ide-cel, bb2121 – BCMA-directed CAR T […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id